Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-25

Clinical Trial Update: Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether milk thistle extract can protect kidney function in patients with diabetic nephropathy. The study has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milk Thistle Extract (silymarin extract)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED